US Patent 7585996 Acyloxyalkyl carbamate prodrugs, methods of synthesis and use
Patent 7585996 was granted and assigned to Xenoport, Inc. on September, 2009 by the United States Patent and Trademark Office.
All edits
Acyloxyalkyl carbamate prodrugs of 3-aminopropylphosphinic acid and analogs thereof, methods of making acyloxyalkyl carbamate prodrugs of 3-aminopropylphosphinic acid and analogs thereof, methods of using acyloxyalkyl carbamate prodrugs of 3-aminopropylphosphinic acid and analogs thereof, and pharmaceutical compositions comprising acyloxyalkyl carbamate prodrugs 3-aminopropylphosphinic acid and analogs thereof for treating diseases or disorders such as mild cognitive impairment, cognitive impairment associated with Alzheimer's disease Alzheimer's disease, depression, anxiety, and epilepsy are disclosed. Acyloxyalkyl carbamate prodrugs of 3-aminopropylphosphinic acid and analogs thereof, which are suitable for oral administration and sustained release oral dosage forms are also disclosed.
US Patent 07585996 Acyloxyalkyl carbamate prodrugs, methods of synthesis and use US Patent 7585996 Acyloxyalkyl carbamate prodrugs, methods of synthesis and use
US Patent 07585996 Acyloxyalkyl carbamate prodrugs, methods of synthesis and use
Find more entities like US Patent 7585996 Acyloxyalkyl carbamate prodrugs, methods of synthesis and use
